Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DNAH8 DNAH14	5.60e-05	18	84	3	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNHD1 DNAH8 DNAH14	2.18e-04	28	84	3	GO:0051959
GeneOntologyMolecularFunction	clathrin light chain binding	CLTCL1 CLTC	3.62e-04	7	84	2	GO:0032051
GeneOntologyMolecularFunction	IgG receptor activity	FCGR2C FCGR2B	3.62e-04	7	84	2	GO:0019770
GeneOntologyMolecularFunction	snoRNA binding	BYSL HEATR1 PRKDC	3.91e-04	34	84	3	GO:0030515
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNHD1 DNAH8 DNAH14	5.03e-04	37	84	3	GO:0045505
GeneOntologyMolecularFunction	IgG binding	FCGR2C FCGR2B	9.38e-04	11	84	2	GO:0019864
GeneOntologyCellularComponent	intracellular protein-containing complex	PRAMEF7 POLR3B FBH1 RARS1 DCAF8L2 LARS1 PRKDC FBXO32 TAF6 PRAMEF8 TOPORS DICER1 TRAPPC9	1.13e-04	972	83	13	GO:0140535
MousePheno	increased chromosomal stability	ZSCAN5B ZSCAN5DP ZSCAN5A ZSCAN5C	4.89e-09	6	61	4	MP:0010095
Domain	SCAN_BOX	ZSCAN5B ZSCAN5DP ZSCAN5A ZSCAN5C ZNF215 ZKSCAN5 ZNF287	6.62e-09	58	83	7	PS50804
Domain	SCAN	ZSCAN5B ZSCAN5DP ZSCAN5A ZSCAN5C ZNF215 ZKSCAN5 ZNF287	6.62e-09	58	83	7	PF02023
Domain	SCAN_dom	ZSCAN5B ZSCAN5DP ZSCAN5A ZSCAN5C ZNF215 ZKSCAN5 ZNF287	6.62e-09	58	83	7	IPR003309
Domain	Retrov_capsid_C	ZSCAN5B ZSCAN5DP ZSCAN5A ZSCAN5C ZNF215 ZKSCAN5 ZNF287	7.49e-09	59	83	7	IPR008916
Domain	SCAN	ZSCAN5B ZSCAN5A ZSCAN5C ZNF215 ZKSCAN5 ZNF287	1.74e-07	56	83	6	SM00431
Domain	Clathrin_H-chain_propeller_rpt	CLTCL1 CLTC	1.95e-05	2	83	2	IPR022365
Domain	Clathrin-link	CLTCL1 CLTC	1.95e-05	2	83	2	PF09268
Domain	-	CLTCL1 CLTC	1.95e-05	2	83	2	2.130.10.110
Domain	Clathrin_H-chain_link/propller	CLTCL1 CLTC	1.95e-05	2	83	2	IPR016025
Domain	Clathrin_propel	CLTCL1 CLTC	1.95e-05	2	83	2	PF01394
Domain	Clathrin_heavy_chain	CLTCL1 CLTC	1.95e-05	2	83	2	IPR016341
Domain	Clathrin_H-chain_linker_core	CLTCL1 CLTC	1.95e-05	2	83	2	IPR015348
Domain	Clathrin_H-chain_propeller_N	CLTCL1 CLTC	1.95e-05	2	83	2	IPR001473
Domain	Dynein_HC_stalk	DNHD1 DNAH8 DNAH14	2.97e-05	14	83	3	IPR024743
Domain	MT	DNHD1 DNAH8 DNAH14	2.97e-05	14	83	3	PF12777
Domain	DHC_fam	DNHD1 DNAH8 DNAH14	3.70e-05	15	83	3	IPR026983
Domain	Dynein_heavy_dom	DNHD1 DNAH8 DNAH14	3.70e-05	15	83	3	IPR004273
Domain	Dynein_heavy	DNHD1 DNAH8 DNAH14	3.70e-05	15	83	3	PF03028
Domain	Clathrin_H-chain_linker	CLTCL1 CLTC	5.84e-05	3	83	2	IPR012331
Domain	CLH	CLTCL1 CLTC	5.84e-05	3	83	2	SM00299
Domain	Clathrin	CLTCL1 CLTC	4.04e-04	7	83	2	PF00637
Domain	CHCR	CLTCL1 CLTC	4.04e-04	7	83	2	PS50236
Domain	Clathrin_H-chain/VPS_repeat	CLTCL1 CLTC	5.37e-04	8	83	2	IPR000547
Domain	TPR-like_helical_dom	CFAP54 CLTCL1 CLTC PRKDC TTC3 ZMYND12	5.99e-04	233	83	6	IPR011990
Domain	ARM-type_fold	CLTCL1 CLTC LRRK2 HEATR5A HEATR1 PRKDC TAF6	7.77e-04	339	83	7	IPR016024
Domain	Leu-rich_rpt_4	LRRK2 LRRIQ4	8.58e-04	10	83	2	IPR025875
Domain	LRR_4	LRRK2 LRRIQ4	8.58e-04	10	83	2	PF12799
Domain	-	RARS1 LARS1	1.05e-03	11	83	2	1.10.730.10
Domain	Dynein_heavy_chain_D4_dom	DNAH8 DNAH14	1.72e-03	14	83	2	IPR024317
Domain	Dynein_heavy_dom-2	DNHD1 DNAH8	1.72e-03	14	83	2	IPR013602
Domain	DHC_N2	DNHD1 DNAH8	1.72e-03	14	83	2	PF08393
Domain	AAA_8	DNAH8 DNAH14	1.72e-03	14	83	2	PF12780
Domain	tRNAsynth_Ia_anticodon-bd	RARS1 LARS1	1.97e-03	15	83	2	IPR009080
Domain	SMAD_dom-like	IRF7 SMAD7	2.25e-03	16	83	2	IPR017855
Domain	-	IRF7 SMAD7	2.25e-03	16	83	2	2.60.200.10
Domain	-	CFAP54 CLTCL1 CLTC TTC3 ZMYND12	2.30e-03	207	83	5	1.25.40.10
Domain	aa-tRNA-synth_I_CS	RARS1 LARS1	2.85e-03	18	83	2	IPR001412
Domain	-	PRAMEF7 NLRP9 LRRK2 LRRIQ4 PRAMEF8 NLRP13	3.06e-03	321	83	6	3.80.10.10
Domain	-	LRRK2 HEATR5A HEATR1 PRKDC TAF6	3.11e-03	222	83	5	1.25.10.10
Domain	PRAME_family	PRAMEF7 PRAMEF8	3.18e-03	19	83	2	IPR026271
Domain	AA_TRNA_LIGASE_I	RARS1 LARS1	3.18e-03	19	83	2	PS00178
Domain	L_dom-like	PRAMEF7 NLRP9 LRRK2 LRRIQ4 PRAMEF8 NLRP13	3.41e-03	328	83	6	IPR032675
Domain	HEAT_REPEAT	HEATR5A HEATR1 PRKDC	3.74e-03	70	83	3	PS50077
Domain	DAPIN	NLRP9 NLRP13	4.25e-03	22	83	2	PS50824
Domain	PYRIN	NLRP9 NLRP13	4.25e-03	22	83	2	PF02758
Domain	DAPIN	NLRP9 NLRP13	4.25e-03	22	83	2	IPR004020
Domain	PYRIN	NLRP9 NLRP13	4.25e-03	22	83	2	SM01289
Domain	TPR-contain_dom	VPS13A PRKDC TTC3 ZMYND12	4.49e-03	150	83	4	IPR013026
Domain	NACHT	NLRP9 NLRP13	4.65e-03	23	83	2	PS50837
Pubmed	Zscan5b Deficiency Impairs DNA Damage Response and Causes Chromosomal Aberrations during Mitosis.	ZSCAN5B ZSCAN5DP ZSCAN5A ZSCAN5C	3.48e-11	4	86	4	31155506
Pubmed	ZSCAN5B and primate-specific paralogs bind RNA polymerase III genes and extra-TFIIIC (ETC) sites to modulate mitotic progression.	ZSCAN5B ZSCAN5DP ZSCAN5A ZSCAN5C	3.48e-11	4	86	4	27732952
Pubmed	ZAR1 and ZAR2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mRNA translational activation.	PRAMEF7 ZSCAN5B ZSCAN5DP ZSCAN5A ZSCAN5C PRAMEF8	6.99e-09	58	86	6	31598710
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	PRAMEF7 ZSCAN5B MMS22L ZSCAN5DP ZSCAN5A ZSCAN5C PRAMEF8 BIRC6 EDNRA	3.02e-07	363	86	9	14691545
Pubmed	NLRP14 deficiency causes female infertility with oocyte maturation defects and early embryonic arrest by impairing cytoplasmic UHRF1 abundance.	ZSCAN5B ZSCAN5DP ZSCAN5A ZSCAN5C	1.19e-06	32	86	4	38060382
Pubmed	Characterization of a second human clathrin heavy chain polypeptide gene (CLH-22) from chromosome 22q11.	CLTCL1 CLTC	6.04e-06	2	86	2	8733129
Pubmed	Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium.	FCGR2C FCGR2B	6.04e-06	2	86	2	2531080
Pubmed	Effects of high-fat diets rich in either omega-3 or omega-6 fatty acids on UVB-induced skin carcinogenesis in SKH-1 mice.	PRKDC HR	6.04e-06	2	86	2	21525235
Pubmed	CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function.	CLTCL1 CLTC	6.04e-06	2	86	2	29097553
Pubmed	Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene.	FCGR2C FCGR2B	6.04e-06	2	86	2	9516136
Pubmed	The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step.	CLTCL1 CLTC	6.04e-06	2	86	2	20065094
Pubmed	Identification of potential protein interactors of Lrrk2.	CLTC LRRK2 PRKDC	6.50e-06	15	86	3	17400507
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	THEMIS2 PRAMEF7 MMS22L UPB1 RARS1 VPS13A LARS1 YDJC IRF7 GSTO2 PRAMEF8 TRAPPC9 ZNF287	1.12e-05	1242	86	13	30973865
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	ARHGEF40 CLTCL1 GPATCH1 CLTC HEATR1 PRKDC	1.14e-05	202	86	6	24639526
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	POLR3B FBH1 MAP1S TRIO USP32 CLTC LARS1 PRKDC TAF6 TTC3 KANK2 ZKSCAN5 DKK3	1.60e-05	1285	86	13	35914814
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ARHGEF40 ATG10 CLTCL1 MAP1S TRIO PFAS PRKDC TTC3 BIRC6 TRAPPC9 SMAD7 HR	1.75e-05	1105	86	12	35748872
Pubmed	Functional equivalence of the clathrin heavy chains CHC17 and CHC22 in endocytosis and mitosis.	CLTCL1 CLTC	1.81e-05	3	86	2	19509056
Pubmed	LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.	CLTC LRRK2	1.81e-05	3	86	2	29735704
Pubmed	Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo.	FCGR2B PRKDC	1.81e-05	3	86	2	22065769
Pubmed	Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOG.	CLTCL1 CLTC	1.81e-05	3	86	2	22891263
Pubmed	Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus.	FCGR2C FCGR2B	1.81e-05	3	86	2	23261299
Pubmed	Functional Fcgamma receptor polymorphisms are associated with human allergy.	FCGR2C FCGR2B	1.81e-05	3	86	2	24586589
Pubmed	Clathrin isoform CHC22, a component of neuromuscular and myotendinous junctions, binds sorting nexin 5 and has increased expression during myogenesis and muscle regeneration.	CLTCL1 CLTC	1.81e-05	3	86	2	15133132
Pubmed	Nonallelic homologous recombination of the FCGR2/3 locus results in copy number variation and novel chimeric FCGR2 genes with aberrant functional expression.	FCGR2C FCGR2B	1.81e-05	3	86	2	26133275
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TDRKH ARFGAP3 GPATCH1 CLTC LRRK2 VPS13A ANKRD28 PRKDC MARVELD2 BIRC6	2.24e-05	777	86	10	35844135
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RLF ARHGEF40 POLR3B RARS1 CLTC LARS1 BYSL ANKRD28 PFAS SAMM50 HEATR1 PRKDC BIRC6	2.74e-05	1353	86	13	29467282
Pubmed	FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival.	FCGR2B PRKDC	3.61e-05	4	86	2	22516957
Pubmed	Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.	FCGR2B HR	3.61e-05	4	86	2	16920988
Pubmed	FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells.	FCGR2B PRKDC	3.61e-05	4	86	2	36759517
Pubmed	HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2.	CLTCL1 CLTC	3.61e-05	4	86	2	11517213
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF7 NLRP9 PRAMEF8	4.57e-05	28	86	3	25089626
Pubmed	Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors.	HEATR1 PRKDC DICER1	5.65e-05	30	86	3	34017080
Pubmed	Autoimmune thyroiditis in Fcgamma receptor-deficient nonobese diabetic mice.	FCGR2B PRKDC	6.01e-05	5	86	2	19447681
Pubmed	The Histone Chaperones ASF1 and CAF-1 Promote MMS22L-TONSL-Mediated Rad51 Loading onto ssDNA during Homologous Recombination in Human Cells.	MMS22L PRKDC	6.01e-05	5	86	2	29478807
Pubmed	SNPs of Fc-gamma receptor genes and chronic periodontitis.	FCGR2C FCGR2B	6.01e-05	5	86	2	20439936
Pubmed	Copy number, linkage disequilibrium and disease association in the FCGR locus.	FCGR2C FCGR2B	6.01e-05	5	86	2	20508037
Pubmed	Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic.	CLTCL1 CLTC	6.01e-05	5	86	2	10436022
Pubmed	MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3.	PRKDC DICER1	6.01e-05	5	86	2	20956382
Pubmed	Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B.	FCGR2C FCGR2B	6.01e-05	5	86	2	19309690
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	POLR3B MAP1S CLTC LARS1 PFAS HEATR1 PRKDC BIRC6 DNAH8	6.22e-05	704	86	9	29955894
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	RARS1 CLTC LARS1 PFAS PRKDC	8.49e-05	179	86	5	36261009
Pubmed	Wnt antagonist gene polymorphisms and renal cancer.	DKK3 SMAD7	9.01e-05	6	86	2	19562778
Pubmed	Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse.	FCGR2B PRKDC	1.26e-04	7	86	2	33117338
Pubmed	The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.	CCNO DICER1	1.26e-04	7	86	2	23849790
Pubmed	A role for the CHC22 clathrin heavy-chain isoform in human glucose metabolism.	CLTCL1 CLTC	1.26e-04	7	86	2	19478182
Pubmed	Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy.	RLF ATG10 RARS1 LARS1 PFAS HEATR1 TAF6	1.36e-04	454	86	7	33226137
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	ARHGEF40 TRIO CLTC PRKDC DICER1	1.50e-04	202	86	5	33005030
Pubmed	Heat shock protein 90 mediates protein-protein interactions between human aminoacyl-tRNA synthetases.	RARS1 LARS1	1.68e-04	8	86	2	10913161
Pubmed	Genetically determined murine models of immunodeficiency.	PRKDC HR	1.68e-04	8	86	2	3297105
Pubmed	Structural analysis of the high molecular mass aminoacyl-tRNA synthetase complex. Effects of neutral salts and detergents.	RARS1 LARS1	1.68e-04	8	86	2	1651330
Pubmed	Regulation of BRCA1 stability through the tandem UBX domains of isoleucyl-tRNA synthetase 1.	RARS1 LARS1	1.68e-04	8	86	2	36347866
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	DNHD1 RARS1 ABCA13 LRRK2 VPS13A	1.71e-04	208	86	5	33230847
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TRIO ANKRD28 PFAS KANK2 DICER1	1.75e-04	209	86	5	36779422
Pubmed	Proteome analysis of the HIV-1 Gag interactome.	RARS1 LARS1 DICER1	1.80e-04	44	86	3	25010285
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DNHD1 RARS1 TRIO CLTC LARS1 BYSL PFAS SAMM50 HEATR1 PRKDC TTC3 DICER1	1.98e-04	1425	86	12	30948266
Pubmed	The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers.	RLF UPB1	2.15e-04	9	86	2	25857663
Pubmed	A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.	RARS1 CLTC LARS1 PRKDC	2.16e-04	118	86	4	27377895
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CLTC BYSL ANKRD28 PFAS HEATR1 PRKDC BIRC6 DICER1	2.17e-04	653	86	8	22586326
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	MMS22L RARS1 CLTC VPS13A SAMM50 HEATR1 PRKDC BIRC6	2.26e-04	657	86	8	36180527
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	PDLIM3 TRIO CLTC ANKRD28 FBXO32 TTC3 BIRC6	2.37e-04	497	86	7	23414517
Pubmed	The human EPRS locus (formerly the QARS locus): a gene encoding a class I and a class II aminoacyl-tRNA synthetase.	RARS1 LARS1	2.68e-04	10	86	2	8188258
Pubmed	The C-terminal appended domain of human cytosolic leucyl-tRNA synthetase is indispensable in its interaction with arginyl-tRNA synthetase in the multi-tRNA synthetase complex.	RARS1 LARS1	2.68e-04	10	86	2	16055448
Pubmed	The appended C-domain of human methionyl-tRNA synthetase has a tRNA-sequestering function.	RARS1 LARS1	2.68e-04	10	86	2	11714285
Pubmed	CALM regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature.	CLTCL1 CLTC	2.68e-04	10	86	2	25898166
Pubmed	Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization.	LRRK2 PRKDC	2.68e-04	10	86	2	19826009
Pubmed	Human cytoplasmic isoleucyl-tRNA synthetase: selective divergence of the anticodon-binding domain and acquisition of a new structural unit.	RARS1 LARS1	2.68e-04	10	86	2	8052601
Pubmed	Evolution of the Glx-tRNA synthetase family: the glutaminyl enzyme as a case of horizontal gene transfer.	RARS1 LARS1	2.68e-04	10	86	2	8078941
Pubmed	Human lysyl-tRNA synthetase accepts nucleotide 73 variants and rescues Escherichia coli double-defective mutant.	RARS1 LARS1	2.68e-04	10	86	2	9278442
Pubmed	The Catalytically Inactive Mutation of the Ubiquitin-Conjugating Enzyme CDC34 Affects its Stability and Cell Proliferation.	ACAD11 LARS1 PFAS SAMM50 PRKDC	3.13e-04	237	86	5	29564676
Pubmed	Dynamic Organization of Aminoacyl-tRNA Synthetase Complexes in the Cytoplasm of Human Cells.	RARS1 LARS1	3.28e-04	11	86	2	19289464
Pubmed	Expression of human aspartyl-tRNA synthetase in Escherichia coli. Functional analysis of the N-terminal putative amphiphilic helix.	RARS1 LARS1	3.28e-04	11	86	2	8449960
Pubmed	Dissection of the structural organization of the aminoacyl-tRNA synthetase complex.	RARS1 LARS1	3.28e-04	11	86	2	19131329
Pubmed	Ubiquitin-specific protease 8 deubiquitinates Sec31A and decreases large COPII carriers and collagen IV secretion.	CLTCL1 CLTC	3.28e-04	11	86	2	29604273
Pubmed	The aftiphilin/p200/gamma-synergin complex.	CLTC HEATR5A	3.28e-04	11	86	2	15758025
Pubmed	STING Gain-of-Function Disrupts Lymph Node Organogenesis and Innate Lymphoid Cell Development in Mice.	IRF7 MADCAM1	3.28e-04	11	86	2	32553167
Pubmed	Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development.	RARS1 CLTC LARS1	3.31e-04	54	86	3	31792442
Pubmed	NODs: intracellular proteins involved in inflammation and apoptosis.	NLRP9 NLRP13	3.93e-04	12	86	2	12766759
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ARHGAP4 TDRKH ARHGEF40 ACAD11 ANKRD28 TAF6 TOPORS KANK2 ZKSCAN5 DICER1	4.33e-04	1116	86	10	31753913
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	RARS1 CLTC HEATR1 PRKDC KANK2	4.45e-04	256	86	5	33397691
Pubmed	Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of protein-protein interactions and characterization of a core protein.	RARS1 LARS1	4.63e-04	13	86	2	9878398
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	SLC6A6 POLR3B TRIO ARFGAP3 ANKRD28 KANK2 BIRC6 DICER1	4.68e-04	733	86	8	34672954
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	PDLIM3 GPATCH1 PARG LARS1 ANKRD28 PFAS HEATR1 PRKDC TAF6	5.07e-04	934	86	9	33916271
Pubmed	EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.	CLTC PRKDC BIRC6	5.21e-04	63	86	3	29162697
Pubmed	EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.	MAP1S CLTC VPS13A SAMM50	5.36e-04	150	86	4	32423001
Pubmed	p38 is essential for the assembly and stability of macromolecular tRNA synthetase complex: implications for its physiological significance.	RARS1 LARS1	5.39e-04	14	86	2	12060739
Pubmed	The genetics of NOD-like receptors in Crohn's disease.	NLRP9 NLRP13	5.39e-04	14	86	2	20403135
Pubmed	NALPs: a novel protein family involved in inflammation.	NLRP9 NLRP13	5.39e-04	14	86	2	12563287
Pubmed	Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2.	KLHL6 FBXO32	5.39e-04	14	86	2	29720484
Pubmed	A genome-wide IR-induced RAD51 foci RNAi screen identifies CDC73 involved in chromatin remodeling for DNA repair.	CLTCL1 RARS1 CLTC PRKDC	5.78e-04	153	86	4	27462432
Pubmed	LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool.	CLTC LRRK2	6.21e-04	15	86	2	21307259
Pubmed	RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.	POLR3B RARS1 CLTC LARS1 BYSL PRKDC	6.63e-04	425	86	6	21081503
Pubmed	Physiological and pathophysiological characteristics of ataxin-3 isoforms.	RARS1 CLTC LARS1 BYSL PRKDC	6.79e-04	281	86	5	30455355
Pubmed	JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phase.	ANKRD28 PRKDC	7.09e-04	16	86	2	26291670
Pubmed	Network organization of the human autophagy system.	ATG10 MAP1S CLTC LARS1 PFAS PRKDC	7.66e-04	437	86	6	20562859
Pubmed	Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse.	PRAMEF7 PRAMEF8	8.02e-04	17	86	2	23565261
Pubmed	Mouse Pramel1 regulates spermatogonial development by inhibiting retinoic acid signaling during spermatogenesis.	PRAMEF7 PRAMEF8	8.02e-04	17	86	2	37781892
Pubmed	Characterization of long cDNA clones from human adult spleen. II. The complete sequences of 81 cDNA clones.	DNHD1 ARHGEF40	8.02e-04	17	86	2	12693554
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	POLR3B CLTCL1 CLTC LARS1 ANKRD28 IRF7 SAMM50 HEATR1 PRKDC DICER1 TRAPPC9	8.37e-04	1440	86	11	30833792
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	ACAD11 MAP1S ANKRD28 PRKDC BIRC6 TRAPPC9	8.52e-04	446	86	6	24255178
Pubmed	The promoter of the oocyte-specific gene, Oog1, functions in both male and female meiotic germ cells in transgenic mice.	PRAMEF7 PRAMEF8	9.01e-04	18	86	2	23894331
Cytoband	19q13.43	ZSCAN5B ZSCAN5DP ZSCAN5A ZSCAN5C NLRP13	6.71e-07	87	86	5	19q13.43
GeneFamily	Dyneins, axonemal	DNAH8 DNAH14	1.33e-03	17	58	2	536
GeneFamily	Aminoacyl tRNA synthetases, Class I	RARS1 LARS1	1.67e-03	19	58	2	131
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	RLF ZSCAN5B ZSCAN5DP ZSCAN5A ZSCAN5C ZNF215 ZKSCAN5 ZNF287	1.97e-03	718	58	8	28
GeneFamily	PRAME family	PRAMEF7 PRAMEF8	2.67e-03	24	58	2	686
GeneFamily	NLR family	NLRP9 NLRP13	2.89e-03	25	58	2	666
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	NLRP9 NLRP13	2.89e-03	25	58	2	994
GeneFamily	Cyclins\|F-boxes other	FBH1 FBXO32	6.94e-03	39	58	2	560
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	THEMIS2 TDRKH GPATCH1 PARG LRRK2 PRKDC	1.59e-06	185	86	6	daea170d827226dda6750bf1838ffd82f070c4d4
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP32 CLTC HEATR5A PRKDC MARVELD2 BIRC6	2.04e-06	193	86	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHL6 TDRKH YDJC DNAH8 ZNF287	8.27e-06	142	86	5	a88bf4bcc80206b16dcc504cc19a3380d01e34a4
ToppCell	Tuft-tuft-3\|World / Class top	BYSL CCNO LRRIQ4 ZKSCAN5 DKK3	1.01e-05	148	86	5	f4f59b46a79fc9aa4c5d330a7b37b1a34a6d71cc
ToppCell	3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T\|bone_marrow / Manually curated celltypes from each tissue	ABCA13 DYTN ANKRD28 COL6A5 LRRIQ4	2.09e-05	172	86	5	a66402d15853f0c9e3d06394ff9ac08d1da128ff
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FANCC SLC6A6 CFAP54 ABCA13 LRRK2	2.67e-05	181	86	5	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2\|TCGA-Skin / Sample_Type by Project: Shred V9	USP32 CLTC ANKRD28 HEATR5A DYRK3	2.67e-05	181	86	5	9d5b331cabc5524f0a9fd8b571e87be4c447c7d4
ToppCell	COPD-Lymphoid-B_Plasma\|Lymphoid / Disease state, Lineage and Cell class	KLHL6 CFAP54 TRIO ANKRD28 ZNF215	2.74e-05	182	86	5	19db653fe04c5e2957eea1f4893b1c1fca4ddcbd
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KLHL6 CFAP54 FBH1 ANKRD28 ZNF215	2.96e-05	185	86	5	3b77bc49cd3740acc025e162a36282ac09e12198
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	MMS22L CLTC HEATR1 PRKDC BIRC6	2.96e-05	185	86	5	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FANCC SLC6A6 CFAP54 ABCA13 LRRK2	3.04e-05	186	86	5	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	MMS22L CLTC HEATR1 PRKDC BIRC6	3.04e-05	186	86	5	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFAP54 TRIO ABCA13 LRRK2 DNAH14	3.20e-05	188	86	5	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDLIM3 FBXO32 KANK2 DKK3 EDNRA	3.28e-05	189	86	5	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFAP54 TRIO ABCA13 LRRK2 DNAH14	3.45e-05	191	86	5	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDLIM3 FBXO32 KANK2 DKK3 EDNRA	3.45e-05	191	86	5	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDLIM3 FBXO32 KANK2 DKK3 EDNRA	3.45e-05	191	86	5	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A6 PDLIM3 DKK3 SMAD7 HR	3.45e-05	191	86	5	8691eba35793e4e90f93d50c2145847ee51289f7
ToppCell	facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A6 UPB1 PDLIM3 DKK3 EDNRA	3.62e-05	193	86	5	eba3c70701b051bc1ed1f4db9270cb27a77ffc3e
ToppCell	facs-Skin-Anagen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A6 UPB1 PDLIM3 DKK3 EDNRA	3.71e-05	194	86	5	5d30d3d41d5f19cdf3077cc609aa2738762cb8c5
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A6 PDLIM3 FBXO32 DKK3 SMAD7	3.81e-05	195	86	5	f41a68b7c2621594db8d8952e301eeadc96be26f
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	PDLIM3 COL6A5 KANK2 DKK3 EDNRA	4.00e-05	197	86	5	6c57ab2efb8363828e24211c4d45e58bb73a9a4d
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	SLC6A6 FBXO32 TTC3 DKK3 HR	4.09e-05	198	86	5	196257c4420ac801ed9fbb444f11718adb7560ae
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	PDLIM3 FBXO32 KANK2 DKK3 EDNRA	4.19e-05	199	86	5	471738f2059e20407572d9c4cbd11812068333ea
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 FCGR2B USP32 LRRK2 HEATR5A	4.19e-05	199	86	5	4e0b73d88b1345ec63a9e5629762341e75beb47f
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PDLIM3 COL6A5 KANK2 DKK3 EDNRA	4.19e-05	199	86	5	e1f1950d6f840485e263b83dc81b98910be3ae7a
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PDLIM3 FBXO32 KANK2 DKK3 EDNRA	4.19e-05	199	86	5	706b7de777ff86eb22e538ccd5c2987ceb6be308
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDLIM3 FBXO32 KANK2 DKK3 EDNRA	4.19e-05	199	86	5	690a4f84b205532c4c9e5c19d5ae430d0655f421
ToppCell	18-Airway-Mesenchymal-Mesenchyme_SERPINF1-high\|Airway / Age, Tissue, Lineage and Cell class	PDLIM3 TTC3 KANK2 DKK3 EDNRA	4.29e-05	200	86	5	14ae55660f7412518dcb5cb982f6fe9f23553cfb
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PDLIM3 FBXO32 KANK2 DKK3 EDNRA	4.29e-05	200	86	5	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	PDLIM3 FBXO32 KANK2 DKK3 EDNRA	4.29e-05	200	86	5	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDLIM3 FBXO32 KANK2 DKK3 EDNRA	4.29e-05	200	86	5	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PDLIM3 COL6A5 KANK2 DKK3 EDNRA	4.29e-05	200	86	5	cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	KLHL6 THEMIS2 ARHGAP4 FCGR2C GAB3	4.29e-05	200	86	5	74ceebee9af63f8b3ec5857eff1b662752bc3862
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	PDLIM3 FBXO32 KANK2 DKK3 EDNRA	4.29e-05	200	86	5	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDLIM3 FBXO32 KANK2 DKK3 EDNRA	4.29e-05	200	86	5	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACAD11 ABCA13 LRRK2 ISM2	1.36e-04	135	86	4	8521107817df49efd9a2e81078c8535ed33e729c
ToppCell	Cerebellum-Macroglia-CSF_related\|Cerebellum / BrainAtlas - Mouse McCarroll V32	CFAP54 COL6A5 MADCAM1 DNAH14	1.44e-04	137	86	4	f004199b654143e9e766e5c5f56858089e98cf5f
ToppCell	Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	CFAP54 COL6A5 MADCAM1 DNAH14	1.44e-04	137	86	4	6a5599af9d0ee1be6cac17af09aa4cd50774c683
ToppCell	Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	CFAP54 COL6A5 MADCAM1 DNAH14	1.44e-04	137	86	4	01cbc9082e10ef51a1763a8b2d708eea0434490f
ToppCell	Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	CFAP54 COL6A5 MADCAM1 DNAH14	1.44e-04	137	86	4	a22730b6f78b66bb3c46155af37c34e554672dee
ToppCell	Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS\|Cerebellum / BrainAtlas - Mouse McCarroll V32	CFAP54 COL6A5 MADCAM1 DNAH14	1.44e-04	137	86	4	ce7c57dad201bd2164fc8b1172aca709f3f7def2
ToppCell	Control-Myeloid-Dendritic_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KLHL6 THEMIS2 IRF7 DYRK3	1.70e-04	143	86	4	bb8d4c335682d1a6798bed0de8bb0603054a4944
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	THEMIS2 ARHGEF40 LRRK2 DICER1	1.74e-04	144	86	4	b638398f559e7fd9d4294d1c830beeb20f905960
ToppCell	Control-Myeloid-Dendritic_cells-pDC\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KLHL6 THEMIS2 IRF7 DYRK3	1.79e-04	145	86	4	bab85a72142b6257f7d424e5301f65b6dcdf745d
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	PDLIM3 LRRIQ4 KANK2 EDNRA	2.61e-04	160	86	4	fd14dfeb7021a4b7299371854dc8fc1fd66c8dae
ToppCell	COVID-19-kidney-Plasma\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KLHL6 CFAP54 ANKRD28 ZNF215	2.61e-04	160	86	4	f8d9e459976e711e9ad39ea2b6173140c0589d6e
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 FCGR2B COL6A5 IRF7	2.61e-04	160	86	4	cfd005e98944817458e8ef9e0c436d77f50c1ad1
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	FCGR2C FCGR2B ARFGAP3 LRRIQ4	2.86e-04	164	86	4	3c15e9b8403b03d67f6ecd7861dc19f1261e3244
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A6 ABCA13 LRRK2 GYG2	2.86e-04	164	86	4	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAB3 PRKDC EDNRA DYRK3	2.93e-04	165	86	4	475905d608fac628960188ae4a18010b8097417e
ToppCell	343B-Lymphocytic-ILC\|343B / Donor, Lineage, Cell class and subclass (all cells)	KLHL6 ANKRD28 HEATR5A HEATR1	3.00e-04	166	86	4	a54377c703efff42d2cc1a8fdb610facc58053dd
ToppCell	facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A6 UPB1 DKK3 EDNRA	3.07e-04	167	86	4	78909f685ccd1321064eb0887caf9263e0e54879
ToppCell	Children_(3_yrs)-Immune-enucleated_erythrocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	UPB1 FCGR2B ABCA13 SAMM50	3.14e-04	168	86	4	8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1S ANKRD28 TRAPPC9 DYRK3	3.14e-04	168	86	4	b9db0b1e4fe54a1fe79530d15d206155a1bfac39
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL6 THEMIS2 FCGR2B GAB3	3.21e-04	169	86	4	b2fdf9f842dc7c181bc951a8a6932c916ed835ef
ToppCell	droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 IRF7 KANK2 HR	3.21e-04	169	86	4	7962165cab84af73d20b56eb70b1ed87c94025ef
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	THEMIS2 FCGR2C FCGR2B ABCA13	3.21e-04	169	86	4	c100a91be9b94bd433a3b172f4a1bfb9d2393003
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL6 THEMIS2 FCGR2B GAB3	3.21e-04	169	86	4	2322f03a115c662f808ebfc892192b7d38d48181
ToppCell	Basal_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	FBXO32 DKK3 EDNRA HR	3.28e-04	170	86	4	776d4224a682b6c648041827efd69794f88906f0
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABCA13 ZSCAN5A DICER1 DYRK3	3.28e-04	170	86	4	0f215911b5880eeffeb43230f7eeaf55b612eaf2
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	LRRK2 PFAS IRF7 KANK2	3.28e-04	170	86	4	07b561cd9c528bc8444c9385e1de621eee7b697e
ToppCell	droplet-Pancreas-Endocrine-21m-Hematologic-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHL6 ARHGAP4 FCGR2B LRRK2	3.28e-04	170	86	4	6086d658a52a1961a1e293cbc3703ae8d309cd11
ToppCell	COVID-19-kidney-Plasma\|kidney / Disease (COVID-19 only), tissue and cell type	KLHL6 THEMIS2 CFAP54 ZNF215	3.36e-04	171	86	4	a59a054b8e119215f24dc5c80ad5a8094b3500f9
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ARHGEF40 MADCAM1 EDNRA ZNF287	3.43e-04	172	86	4	de4961f4037c439d3e0ec706a257b0ec17f4d5be
ToppCell	Control-B_cells-Plasma_cells\|Control / group, cell type (main and fine annotations)	KLHL6 CFAP54 ANKRD28 ZNF215	3.66e-04	175	86	4	fb23858cfce71509cafbe0d9728e678012ff2962
ToppCell	facs-Skin-Anagen-24m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A6 UPB1 DKK3 EDNRA	3.66e-04	175	86	4	5552ff1e13f931c8cd7780726c90b5609497a648
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL6A5 KANK2 DKK3 EDNRA	3.82e-04	177	86	4	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	severe-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SLC6A6 FCGR2B PRKDC TOPORS	3.82e-04	177	86	4	d1ad35ee3d2a84b1d01126d0a38464ab858c00d0
ToppCell	3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KLHL6 CFAP54 ANKRD28 DYRK3	3.82e-04	177	86	4	b326376e879afef579b1b7094d756aaff0de270b
ToppCell	3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KLHL6 CFAP54 ANKRD28 DYRK3	3.82e-04	177	86	4	393882f1bf7658a17e10a771b803339f16fb2e69
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL6A5 KANK2 DKK3 EDNRA	3.82e-04	177	86	4	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FANCC ABCA13 LRRK2 BYSL	3.91e-04	178	86	4	c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-pDC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KLHL6 THEMIS2 ARHGAP4 IRF7	3.91e-04	178	86	4	b7d1d8f76c1c2467b1a39a9b4150ed4a47144a15
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDLIM3 FBXO32 KANK2 DKK3	3.99e-04	179	86	4	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	THEMIS2 TDRKH GPATCH1 PARG	3.99e-04	179	86	4	10c7d371937d9d93c12c8d3465430ef9e0c2ec81
ToppCell	Control-Stromal-SMC\|Control / Disease state, Lineage and Cell class	PDLIM3 KANK2 DKK3 EDNRA	3.99e-04	179	86	4	1378051bc62009eec2dbecf3d5d89baedbeb84eb
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDLIM3 LRRK2 DKK3 SMAD7	4.07e-04	180	86	4	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDLIM3 LRRK2 DKK3 SMAD7	4.07e-04	180	86	4	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FANCC CFAP54 ABCA13 LRRK2	4.25e-04	182	86	4	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THEMIS2 FCGR2B LRRK2 DNAH8	4.43e-04	184	86	4	95cf125127658c4c04445c61809d1aed21ee1f83
ToppCell	343B-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	POLR3B ACAD11 GPATCH1 HEATR5A	4.52e-04	185	86	4	1b8e3ddb91797f84e4b15d2457b0c008e5be50db
ToppCell	343B-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	POLR3B ACAD11 GPATCH1 HEATR5A	4.52e-04	185	86	4	02cbf492bc40abebaa93a3a208888afae72fbe06
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDLIM3 FBXO32 KANK2 DKK3	4.52e-04	185	86	4	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	wk_08-11-Hematologic-Myeloid-Neutrophil\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	THEMIS2 FCGR2C FCGR2B LRRK2	4.52e-04	185	86	4	655fb705d7a029844ecb4f6a53e948e37ee81006
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDLIM3 FBXO32 KANK2 DKK3	4.61e-04	186	86	4	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC2\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THEMIS2 FCGR2C FCGR2B LRRK2	4.61e-04	186	86	4	69b107ad88b07e9aeef09d4e4dac99b0cb6b467e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDLIM3 COL6A5 DKK3 EDNRA	4.61e-04	186	86	4	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA13 LRRK2 ANKRD28 DNAH14	4.61e-04	186	86	4	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFAP54 ABCA13 LRRK2 DNAH14	4.61e-04	186	86	4	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFAP54 ABCA13 LRRK2 DNAH14	4.70e-04	187	86	4	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDLIM3 FBXO32 KANK2 DKK3	4.80e-04	188	86	4	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDLIM3 FBXO32 KANK2 DKK3	4.80e-04	188	86	4	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KLHL6 THEMIS2 FCGR2B ANKRD28	4.80e-04	188	86	4	8e1220066008aef171692c6afffcf31833a3fae8
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KLHL6 THEMIS2 FCGR2B ANKRD28	4.80e-04	188	86	4	31d7e62cce010eed1c2db6d6eb55806d27b26151
ToppCell	343B-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	KLHL6 ANKRD28 HEATR5A HEATR1	4.90e-04	189	86	4	c26428871dc3261327d89cacaba6e21e004ff1f3
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FANCC ABCA13 LRRK2 DNAH14	4.90e-04	189	86	4	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDLIM3 FBXO32 KANK2 DKK3	4.90e-04	189	86	4	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A6 CFAP54 ABCA13 LRRK2	4.90e-04	189	86	4	bd91bdfe35294e60d980259b70fe9e60dca2743f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFAP54 ABCA13 LRRK2 DNAH14	4.99e-04	190	86	4	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
Disease	plexin-B2 measurement	FCGR2C FCGR2B	2.65e-04	9	81	2	EFO_0021867
Disease	malaria (implicated_via_orthology)	FCGR2C FCGR2B	2.65e-04	9	81	2	DOID:12365 (implicated_via_orthology)
Disease	hematocrit	FANCC TDRKH FCGR2C ARHGEF40 ACAD11 FCGR2B YDJC PFAS EDNRA SMAD7	4.43e-04	1011	81	10	EFO_0004348
Disease	low affinity immunoglobulin gamma Fc region receptor II-a measurement	FCGR2C FCGR2B	9.85e-04	17	81	2	EFO_0021969
Disease	Alopecia	EDNRA HR	1.23e-03	19	81	2	C0002170
Disease	low affinity immunoglobulin gamma Fc region receptor II-b measurement	FCGR2C FCGR2B	2.14e-03	25	81	2	EFO_0021970
Disease	attention deficit hyperactivity disorder (implicated_via_orthology)	FBXO32 TRAPPC9	2.69e-03	28	81	2	DOID:1094 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
WLPALHLFDVALKLC	CFAP54	2581	Q96N23
LPWAELICPRFVHKE	ARHGEF40	176	Q8TER5
RKHGTDLWLDSCVVP	ARFGAP3	126	Q9NP61
AWCDLTIHLPAAVLL	BIRC6	3206	Q9NR09
ESRCKLLSWLIPVHR	CCNO	131	P22674
ETIVLRCHSWKDKPL	FCGR2B	146	P31994
DSKWLTPLHRAVASC	ANKRD28	71	O15084
VDPCSRHSLWDILLK	ABCA13	4006	Q86UQ4
ALCWFPLHLSRILKK	EDNRA	316	P25101
RPLTLKDIWEGVHEC	ATG10	121	Q9H0Y0
HPDLPKWLASLEKCL	DNHD1	1441	Q96M86
ELCAIHPIPASLWRK	DICER1	1036	Q9UPY3
HPKECRVIAVLDWEL	ACAD11	231	Q709F0
SWVRHKPSERLCLLP	KLHL6	241	Q8WZ60
LWKRCRHLAEDDTHP	MADCAM1	341	Q13477
ERTLASVCALLVWHP	MAP1S	406	Q66K74
KVPRLICRWTSLHLL	LRRIQ4	271	A6NIV6
LCIKELWVLLIHLLD	MMS22L	291	Q6ZRQ5
PIRVIDLSECAVWKH	GAB3	56	Q8WWW8
PVLACSGLDHDVKIW	DCAF8L2	526	P0C7V8
WHCPFLLETKILERA	HR	141	O43593
LTRDTFEWHPDKLLC	GPATCH1	606	Q9BRR8
ETIVLRCHSWKDKPL	FCGR2C	146	P31995
ILCKGDWSRLHAVLP	ISM2	531	Q6H9L7
PEWERCEKPLTRLHV	PARG	706	Q86W56
LDTCHKLLLIRSWCP	DNAH8	3856	Q96JB1
LDCVSHTPALRLWIS	GSTO2	191	Q9H4Y5
CLALVHLPVEKESWI	LRRK2	2201	Q5S007
VKLEPWLCRVHLEGT	IRF7	451	Q92985
PELGLTLTKLHCWTL	GYG2	111	O15488
LSLVCHLWREIISDP	FBH1	236	Q8NFZ0
APHLPWLCVEKLDLL	FER1L6-AS2	81	Q96M78
HLARVLLLWKCVFPA	HEATR5A	571	Q86XA9
ILLWLPTCHRLSAAE	DYTN	206	A2CJ06
WKSLEECLEKHLPLP	UPB1	6	Q9UBR1
DLIRFLREHSPCWKE	COL6A5	1736	A8TX70
CLWLRHLPSLEKAML	FANCC	241	Q00597
PLTDRCWLTLMEALH	DNAH14	1141	Q0VDD8
PRTLDEVLKWAHCLT	GPR142	306	Q7Z601
LISALVCLKLWRHEA	MARVELD2	356	Q8N4S9
SCWLVKRSHVELLLG	ITIH6	1291	Q6UXX5
EWLRLACRSDAHPEL	KANK2	626	Q63ZY3
CSLHPLLRGWEEALE	HEATR1	631	Q9H583
LHVLSEDRLLWKKLC	FBXO32	256	Q969P5
RTLDECLTHLLEWGK	PRAMEF8	156	Q5VWM4
PKAHIRKLAECIRWS	SAMM50	411	Q9Y512
CHDPASRLLDLITWE	DKK3	241	Q9UBP4
KRELPVLWHQCLLTL	BYSL	371	Q13895
IEFLKRCLHWDPSAR	DYRK3	496	O43781
LDHEKEWKLGRCILR	RARS1	566	P54136
PLDVCLKAHWLSIEG	TAF6	126	P49848
DHPGSLKWDLALCLL	SLC6A6	211	P31641
LCEHIWTLLGKPDSI	LARS1	866	Q9P2J5
LCLKIDRGETHLWSP	PDLIM3	76	Q53GG5
SRLCLEPREHAWILA	SOWAHD	106	A6NJG2
RKEPSLLSPLHCWAV	ARHGAP4	91	P98171
KLLLPWLEARIHEGC	CLTC	856	Q00610
YLVCRKDPELWAHVL	CLTCL1	946	P53675
AALKHPGCSIRELWL	NLRP9	821	Q7RTR0
AKRCWHSLLSVPKIL	TP53TG5	66	Q9Y2B4
RTLDECLTHLLEWGK	PRAMEF7	156	Q5VXH5
PWTKLKTHPICLSLD	UHRF1BP1L	71	A0JNW5
PLLLCKVFRWPDLRH	SMAD7	156	O15105
KLTELCHLWLRPDLH	ZSCAN5DP	61	P0CG00
WVPCLHDETEKLVRK	VPS13A	191	Q96RL7
RELCLKWLRPEIHSK	ZNF287	71	Q9HBT7
RLTHCADWKPLVAKI	TDRKH	441	Q9Y2W6
LRCELLLALKAHWPF	RLF	451	Q13129
CPLLLDDVARESWLL	PFAS	66	O15067
ALRKLTELCHLWLRP	ZSCAN5B	61	A6NJL1
TELCHLWLRPDLHTK	ZSCAN5B	66	A6NJL1
ALKDLVLTCPTLPWH	THEMIS2	186	Q5TEJ8
ALRKLTELCHLWLRP	ZSCAN5A	61	Q9BUG6
TELCHLWLRPDLHTK	ZSCAN5A	66	Q9BUG6
SEPASLKEARCLIWL	TTC3	961	P53804
LKEARCLIWLLEEHR	TTC3	966	P53804
CLIWLLEEHRDKFPA	TTC3	971	P53804
CSWERLHELRVLTAP	YDJC	266	A8MPS7
TVKPCLDLLVNWLHI	RRN3P1	46	Q2M238
KPIWRHEILDADGIC	POLR3B	801	Q9NW08
ASLCLLDLVKWLLAH	PRKDC	1161	P78527
LPLKICLHLGWDEGL	nan	16	Q86TA4
RRLKLAHFCPDTSLW	nan	411	Q3C1V9
WDSIHEKICQLLIPL	ZMYND12	46	Q9H0C1
ACLHRLVPWLKRELT	TOPORS	291	Q9NS56
ELCLQWLRPEIHTKK	ZNF215	71	Q9UL58
LEIHSKLGICWRIPS	TRAPPC9	976	Q96Q05
ALRKLTELCHLWLRP	ZSCAN5C	61	A6NGD5
TELCHLWLRPDLHTK	ZSCAN5C	66	A6NGD5
THCLATKKLDLWRLP	USP32	1261	Q8NFA0
LERPHDKPDWCLVRT	TRIO	1686	O75962
LRVLCCEWLRPELHT	ZKSCAN5	71	Q9Y2L8
CEWLRPELHTKEQIL	ZKSCAN5	76	Q9Y2L8
ALTHPKCALERLELW	NLRP13	861	Q86W25
SRFSILIEAWEHCKP	NAALADL2	741	Q58DX5